CSBR:NASDAQ
Champions Oncology Inc
$4.34
arrow_downward
-1.36%(-0.060) 1D
Nov 20, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.45
High
$4.45
Low
$4.34
Mkt. cap
60.41M
Avg. vol.
6.97K
Volume
8.94K
52-wk high
$8.31
52-wk low
$4.34
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.45
High
$4.45
Low
$4.34
Mkt. cap
60.41M
Avg. vol.
6.97K
Volume
8.94K
52-wk high
$8.31
52-wk low
$4.34
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
Stocktwits
·
1 hour ago
Nasdaq 100 Ends Worst Week Since 2020, S&P 500 In Correction Territory As AI Rout Sours Sentiment — ANT, NVDA, TTWO, ZS, CRWD In Focus
The Motley Fool
·
1 hour ago
Report: Goldman Sachs Predicts the S&P 500 Will Gain 26% in 12 Months
FXStreet
·
5 hours ago
Dow Jones Industrial Average drops for a fifth day as AI rout widens
JournalArta
·
1 hour ago
S&P 500 Sinks 3.7% as AI Stock Sell-Off Deepens
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com